Table 1.
Demographic and Treatment Characteristics of the Patient Sample
MDD (n = 45) | BD (n = 22) | χ2, p | |
---|---|---|---|
n (%) | n (%) | ||
Gender (Male) | 28 (62) | 6 (27) | 7.22, .007 |
Response Rate to Ketamine at 230 Minutes | 17 (38) | 15 (68) | 5.48, .02 |
Mean (SD) | Mean (SD) | t, p | |
---|---|---|---|
Age, Years | 46.8 (12.9) | 44.8 (11.7) | .62, .54 |
Weight | 93.3 (23.5) | 91.5 (19.0) | .33, .75 |
BMI | 30.2 (6.6) | 31.8 (5.9) | −.96, .34 |
Clinical Scales | |||
MADRS | 32.8 (4.7) | 31.7 (3.8) | .98, .33 |
BPRS total | 36.1 (5.9) | 34.9 (4.6) | .88, .38 |
BPRS positive | 9.7 (1.4) | 9.9 (1.5) | −.45, .65 |
CADSS | 4.3 (7.5) | 2.1 (3.4) | 1.36, .18 |
Percent change in MADRSa | −37.3 (32.1) | −46.5 (33.6) | 1.08, .28 |
BD, bipolar depression; BMI, body mass index; BPRS, Brief Psychiatric Rating Scale; CADSS, Clinician Administered Dissociative States Scale; MADRS, Montgomery–Åsberg Depression Rating Scale; MDD, major depressive disorder; SD, standard deviation.
From baseline to end point.